Who owns the CYTOSEN trademark?

The CYTOSEN trademark is owned by KIADIS PHARMA INTELLECTUAL PROPERTY B.V..

What class is the CYTOSEN trademark registered in?

The CYTOSEN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for CYTOSEN?

The USPTO serial number for CYTOSEN is 88048354.

What is the registration number for CYTOSEN?

CYTOSEN is registered under USPTO registration number 0.

CYTOSEN - Owned by KIADIS PHARMA INTELLECTUAL PROPERTY B.V. - (Class 005, Class 042, Class 044)

Full Goods & Services

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Filing Basis & Declarations

Standard Characters ClaimedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1477193

499Jan 23, 2019

Source: USPTO Madrid International Filing Requests

Status History

30 events

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Dec 23, 2020

Code ASGN

ABANDONMENT - NO USE STATEMENT FILED

Jul 06, 2020

Code ABN6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jul 06, 2020

Code MAB6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 06, 2019

Code EXRA

SOU TEAS EXTENSION RECEIVED

Dec 04, 2019

Code EEXT

SOU EXTENSION 1 FILED

Dec 04, 2019

Code EXT1

SOU EXTENSION 1 GRANTED

Dec 04, 2019

Code EX1G

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 04, 2019

Code NOAM

PUBLISHED FOR OPPOSITION

Apr 09, 2019

Code PUBO

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 09, 2019

Code NPUB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 20, 2019

Code NONP

EXAMINERS AMENDMENT -WRITTEN

Mar 05, 2019

Code CNEA

EXAMINERS AMENDMENT E-MAILED

Mar 05, 2019

Code GNEA

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 05, 2019

Code GNEN

EXAMINER'S AMENDMENT ENTERED

Mar 05, 2019

Code XAEC

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 05, 2019

Code CNSA

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Mar 04, 2019

Code ZZZX

WITHDRAWN FROM PUB - OG REVIEW QUERY

Feb 26, 2019

Code PBCR

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 14, 2019

Code PREV

ASSIGNED TO LIE

Feb 11, 2019

Code ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 28, 2019

Code CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 23, 2019

Code TEME

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 22, 2019

Code TROA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 22, 2019

Code CRFA

NON-FINAL ACTION WRITTEN

Nov 20, 2018

Code CNRT

NON-FINAL ACTION E-MAILED

Nov 20, 2018

Code GNRT

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 20, 2018

Code GNRN

ASSIGNED TO EXAMINER

Nov 08, 2018

Code DOCK

NEW APPLICATION ENTERED

Jul 26, 2018

Code NWAP

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 26, 2018

Code NWOS

Other Marks by KIADIS PHARMA INTELLECTUAL PROPERTY B.V.

Additional USPTO filings from the same owner.

NUM

NUMBERS MATTER

88138951

KIADIS PHARMA INTELLECTUAL PROPERTY B.V.

ABANDONED

ACC

ACCELERATING INNOVATION IN NK CELL THERAPY

88048416

KIADIS PHARMA INTELLECTUAL PROPERTY B.V.

ABANDONED

CYT

CYTOSEN THERAPEUTICS

88048381

KIADIS PHARMA INTELLECTUAL PROPERTY B.V.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

CYT

CYTOSEN THERAPEUTICS

88048381

KIADIS PHARMA INTELLECTUAL PROPERTY B.V.

ABANDONED

Other Marks by Matthew J. Smith

Additional USPTO filings handled by the same attorney of record.

EPL

EPLAN EFFICIENT ENGINEERING.

79420421

REGISTERED

REA

READY FOR RILINEX READY FOR RILINEX

79437249

REGISTERED

EPL

EPLAN EFFICIENT ENGINEERING.

79420461

REGISTERED

REA

READY FOR RILINEX READY FOR RILINEX

79437248

REGISTERED

CYTOSEN

Full Goods & Services

Filing Basis & Declarations

International Filings

Other Marks by KIADIS PHARMA INTELLECTUAL PROPERTY B.V.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Matthew J. Smith

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Industries

USPTO Deadlines

Compare

Resources

Company

Exceptions